James Patrick Kelly Novavax Inc (NVAX) insider trading activity

James Patrick Kelly is EVP, CFO and Treasurer of NOVAVAX INC. Currently has a direct ownership of 14,429 shares of NVAX, which is worth approximately $122,069. The most recent transaction as insider was on Aug 16, 2024, when has been sold 1,223 shares (Common Stock) at a price of $12.96 per share, resulting in proceeds of $15,850. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.4K

8.61% 3M change

214.77% 12M change

Total Value Held $122,069

James Patrick Kelly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 16 2024	SELL Payment of exercise price or tax liability	$15,850 $12.96 p/Share	1,223 Reduced 7.81%	14,429 Common Stock
Aug 16 2024	BUY Exercise of conversion of derivative security	$30,676 $12.96 p/Share	2,367 Added 13.14%	15,652 Common Stock
Mar 10 2024	SELL Payment of exercise price or tax liability	$12,131 $5.45 p/Share	2,226 Reduced 14.35%	13,285 Common Stock
Mar 10 2024	BUY Exercise of conversion of derivative security	-	4,608 Added 22.9%	15,511 Common Stock
Mar 07 2024	SELL Payment of exercise price or tax liability	$33,127 $5.61 p/Share	5,905 Reduced 35.13%	10,903 Common Stock
Mar 07 2024	BUY Exercise of conversion of derivative security	-	12,224 Added 42.11%	16,808 Common Stock
Aug 16 2023	SELL Payment of exercise price or tax liability	$8,149 $7.13 p/Share	1,143 Reduced 19.96%	4,584 Common Stock
Aug 16 2023	BUY Exercise of conversion of derivative security	-	2,366 Added 29.24%	5,727 Common Stock
Mar 10 2023	SELL Payment of exercise price or tax liability	$16,110 $6.52 p/Share	2,471 Reduced 42.37%	3,361 Common Stock
Mar 10 2023	BUY Exercise of conversion of derivative security	$30,050 $6.52 p/Share	4,609 Added 44.14%	5,832 Common Stock
Aug 16 2022	SELL Payment of exercise price or tax liability	$49,055 $42.88 p/Share	1,144 Reduced 48.33%	1,223 Common Stock
Aug 16 2022	BUY Exercise of conversion of derivative security	-	2,367 Added 50.0%	2,367 Common Stock

Also insider at

SUPN

SUPERNUS PHARMACEUTICALS, INC. Healthcare

Executive Vice-President & CFO

JPK